ArticleFrontiers in pharmacology2024

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region.

Kristen Kopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.